Next Article in Journal
Use, Risk and Revalorization of Veterinary Antibiotics: A Canadian Perspective
Previous Article in Journal
Determinants of Tuberculosis Treatment Outcomes in Patients with TB/HIV Co-Infection During Tuberculosis Treatment at Selected Level One Hospitals in Lusaka, Zambia
Previous Article in Special Issue
Antimicrobial Therapies for Early-Onset Group B Streptococcal Sepsis: Insights from an Italian Multicenter Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Congenital Candida krusei Sepsis in an Extremely Preterm Baby: Case Report and Literature Review

1
Department of Neonatology, Institute for Maternal and Child Health, IRCCS Burlo Garofolo, 34137 Trieste, Italy
2
Department of Medical, Surgical and Health Sciences, University of Trieste, 34127 Trieste, Italy
3
Department of Obstetrics and Gynecology, Institute for Maternal and Child Health, IRCCS Burlo Garofolo, 34137 Trieste, Italy
4
Department of Pediatrics and Neonatology, University Hospital Degli Infermi, 13875 Biella, Italy
*
Author to whom correspondence should be addressed.
Antibiotics 2025, 14(7), 666; https://doi.org/10.3390/antibiotics14070666
Submission received: 3 May 2025 / Revised: 23 June 2025 / Accepted: 23 June 2025 / Published: 30 June 2025

Abstract

A preterm neonate born at 24 + 5 weeks gestation developed congenital Candida krusei sepsis, diagnosed via placental culture, axillary swab, and elevated beta-glucan levels. Although initial blood cultures were negative, continuous HeRo monitoring played a crucial role in the early detection of clinical deterioration, prompting timely antifungal therapy with amphotericin B followed by micafungin. This proactive approach, combining prompt diagnosis, HeRo surveillance, and tailored treatment, ensured a favorable outcome. Our case underscores the value of HeRo monitoring as an early warning tool in managing neonatal fungal infections.
Keywords: congenital candida; Candida krusei; preterm baby congenital candida; Candida krusei; preterm baby

Share and Cite

MDPI and ACS Style

Cossovel, F.; Nider, S.; Bua, J.; Ghirigato, E.; Piccoli, M.; Manzoni, P.; Travan, L. Congenital Candida krusei Sepsis in an Extremely Preterm Baby: Case Report and Literature Review. Antibiotics 2025, 14, 666. https://doi.org/10.3390/antibiotics14070666

AMA Style

Cossovel F, Nider S, Bua J, Ghirigato E, Piccoli M, Manzoni P, Travan L. Congenital Candida krusei Sepsis in an Extremely Preterm Baby: Case Report and Literature Review. Antibiotics. 2025; 14(7):666. https://doi.org/10.3390/antibiotics14070666

Chicago/Turabian Style

Cossovel, Francesca, Silvia Nider, Jenny Bua, Elena Ghirigato, Monica Piccoli, Paolo Manzoni, and Laura Travan. 2025. "Congenital Candida krusei Sepsis in an Extremely Preterm Baby: Case Report and Literature Review" Antibiotics 14, no. 7: 666. https://doi.org/10.3390/antibiotics14070666

APA Style

Cossovel, F., Nider, S., Bua, J., Ghirigato, E., Piccoli, M., Manzoni, P., & Travan, L. (2025). Congenital Candida krusei Sepsis in an Extremely Preterm Baby: Case Report and Literature Review. Antibiotics, 14(7), 666. https://doi.org/10.3390/antibiotics14070666

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop